Expanded Hemodialysis: A New Therapy for a New Class of Membranes

Contributions to Nephrology

Volumn 190, Issue , 2017, Pages 124-133

  Ronco, Claudio ^a   La Manna, Gaetano ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL MEMBRANE; CHRONIC KIDNEY FAILURE; DEVICES; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; MOLECULAR WEIGHT; PROCEDURES;

HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; MOLECULAR WEIGHT; RENAL DIALYSIS;

EID: 85020273674     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000468959     Document Type: Article

References (25)

1. Vanholder R, de Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943.
2. Neirynck N, Vanholder R, Schepers E, Eloot S, Pletinck A, Glorieux G: An update on uremic toxins. Int Urol Nephrol 2013; 45: 139-150.
3. Miyata T, Jadoul M, Kurokawa K, van Ypersele de Strihou C: Beta-2 microglobulin in renal disease. J Am Soc Nephrol 1998; 9: 1723-1735.
4. Cianciolo G, Coli L, La Manna G, Donati G, D'Addio F, Comai G, Ricci D, Dormi A, Wratten M, Feliciangeli G, Stefoni S: Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach. Int J Artif Organs 2007; 30: 864-878.
5. Cianciolo G, La Manna G, Coli L, Donati G, D'Addio F, Persici E, Comai G, Wratten M, Dormi A, Mantovani V, Grossi G, Stefoni S: 5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients. Am J Nephrol 2008; 28: 941-948.
6. Desjardins L, Liabeuf S, Lenglet A, Lemke HD, Vanholder R, Choukroun G, Massy ZA; European Uremic Toxin (EUTox) Work Group: Association between free light chain levels, and disease progression and mortality in chronic kidney disease. Toxins (Basel) 2013; 5: 2058-2073.
7. Ronco C, Crepaldi C, Brendolan A, Bragantini L, d'Intini V, Inguaggiato P, Bonello M, Krause B, Deppisch R, Goehl H, Scabardi A: Evolution of synthetic membranes for blood purification: the case of the Polyflux family. Nephrol Dial Transplant 2003; 18(suppl 7):10-20.
8. Ronco C: Hemodiafiltration: evolution of a technique towards better dialysis care. Contrib Nephrol 2011; 168: 19-27.
9. Ronco C: Hemodiafiltration: technical and clinical issues. Blood Purif 2015; 40(suppl 1):2-11.
10. Coli L, La Manna G, Comai G, Ursino M, Ricci D, Piccari M, Locatelli F, Di Filippo S, Cristinelli L, Bacchi M, Balducci A, Aucella F, Panichi V, Ferrandello FP, Tarchini R, Lambertini D, Mura C, Marinangeli G, Di Loreto E, Quarello F, Forneris G, Tancredi M, Morosetti M, Palombo G, Di Luca M, Martello M, Emiliani G, Bellazzi R, Stefoni S: Automatic adaptive system dialysis for hemodialysis-associated hypotension and intolerance: a noncontrolled multicenter trial. Am J Kidney Dis 2011; 58: 93-100.
11. Ward RA: Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application? J Am Soc Nephrol 2005; 16: 2421-2430.
12. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-736.
13. Kirsch AH, Lyko R, Nilsson LG, Beck W, Amdahl M, Lechner P, Schneider A, Wanner C, Rosenkranz AR, Krieter DH: Performance of hemodialysis with novel medium cut-off dialyzers. Nephrol Dial Transplant 2016;pii:gfw310.
14. Zickler D, Schindler R, Willy K, Martus P, Pawlak M, Storr M, Hulko M, Boehler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Fiedler R, Girndt M: Medium cut-off (MCO) membranes reduce inflammation in chronic dialysis patients-A randomized controlled clinical trial. PLoS One 2017; 12:e0169024.
15. Boschetti-de-Fierro A, Voigt M, Storr M, Krause B: Extended characterization of a new class of membranes for blood purification: the high cut-off membranes. Int J Artif Organs 2013; 36: 455-463.
16. Boschetti-de-Fierro A, Voigt M, Storr M, Krause B: MCO membranes: enhanced selectivity in high-flux class. Sci Rep 2015; 5: 18448.
17. Ronco C, Brendolan A, Lupi A, Metry G, Levin NW: Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int 2000; 58: 809-817.
18. Fiore GB, Guadagni G, Lupi A, Ricci Z, Ronco C: A new semiempirical mathematical model for prediction of internal filtration in hollow fiber hemodialyzers. Blood Purif 2006; 24: 555-568.
19. Fiore GB, Ronco C: Principles and practice of internal hemodiafiltration. Contrib Nephrol 2007; 158: 177-184.
20. Ronco C: Fluid mechanics and crossfiltration in hollow-fiber hemodialyzers. Contrib Nephrol 2007; 158: 34-49.
21. Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, Soler J, Torres F, Campistol JM, Martinez-Castelao A; ESHOL Study Group: High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013; 24: 487-497.
22. Ronco C, Brendolan A, Feriani M, Milan M, Conz P, Lupi A, Berto P, Bettini M, La Greca G: A new scintigraphic method to characterize ultrafiltration in hollow fiber dialyzers. Kidney Int 1992; 41: 1383-1393.
23. Weber V, Linsberger I, Rossmanith E, Weber C, Falkenhagen D: Pyrogen transfer across high-and low-flux hemodialysis membranes. Artif Organs 2004; 28: 210-217.
24. Coli L, Donati G, Cappuccilli ML, Cianciolo G, Comai G, Cuna V, Carretta E, La Manna G, Stefoni S: Role of the hemodialysis vascular access type in inflammation status and monocyte activation. Int J Artif Organs 2011; 34: 481-488.
25. Rangel AV, Kim JC, Kaushik M, Garzotto F, Neri M, Cruz DN, Ronco C: Backfiltration: past, present and future. Contrib Nephrol 2011; 175: 35-45.